Cargando…

Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism

INTRODUCTION: Neuroinflammation and metabolic dysfunction are early alterations in Alzheimer’s disease (AD) brain that are thought to contribute to disease onset and progression. Glial activation due to protein deposition results in cytokine secretion and shifts in brain metabolism, which have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhn, Madison K., Fleeman, Rebecca M., Beidler, Lynne M., Snyder, Amanda M., Chan, Dennis C., Proctor, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550897/
https://www.ncbi.nlm.nih.gov/pubmed/37811007
http://dx.doi.org/10.1007/s12195-023-00782-y
_version_ 1785115646767398912
author Kuhn, Madison K.
Fleeman, Rebecca M.
Beidler, Lynne M.
Snyder, Amanda M.
Chan, Dennis C.
Proctor, Elizabeth A.
author_facet Kuhn, Madison K.
Fleeman, Rebecca M.
Beidler, Lynne M.
Snyder, Amanda M.
Chan, Dennis C.
Proctor, Elizabeth A.
author_sort Kuhn, Madison K.
collection PubMed
description INTRODUCTION: Neuroinflammation and metabolic dysfunction are early alterations in Alzheimer’s disease (AD) brain that are thought to contribute to disease onset and progression. Glial activation due to protein deposition results in cytokine secretion and shifts in brain metabolism, which have been observed in AD patients. However, the mechanism by which this immunometabolic feedback loop can injure neurons and cause neurodegeneration remains unclear. METHODS: We used Luminex XMAP technology to quantify hippocampal cytokine concentrations in the 5xFAD mouse model of AD at milestone timepoints in disease development. We used partial least squares regression to build cytokine signatures predictive of disease progression, as compared to healthy aging in wild-type littermates. We applied the disease-defining cytokine signature to wild-type primary neuron cultures and measured downstream changes in gene expression using the NanoString nCounter system and mitochondrial function using the Seahorse Extracellular Flux live-cell analyzer. RESULTS: We identified a pattern of up-regulated IFNγ, IP-10/CXCL10, and IL-9 as predictive of advanced disease. When healthy neurons were exposed to these cytokines in proportions found in diseased brain, gene expression of mitochondrial electron transport chain complexes, including ATP synthase, was suppressed. In live cells, basal and maximal mitochondrial respiration were impaired following cytokine stimulation. CONCLUSIONS: We identify a pattern of cytokine secretion predictive of progressing amyloid-β pathology in the 5xFAD mouse model of AD that reduces expression of mitochondrial electron transport complexes and impairs mitochondrial respiration in healthy neurons. We establish a mechanistic link between disease-specific immune cues and impaired neuronal metabolism, potentially causing neuronal vulnerability and susceptibility to degeneration in AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12195-023-00782-y.
format Online
Article
Text
id pubmed-10550897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-105508972023-10-06 Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism Kuhn, Madison K. Fleeman, Rebecca M. Beidler, Lynne M. Snyder, Amanda M. Chan, Dennis C. Proctor, Elizabeth A. Cell Mol Bioeng SI: 2023 CMBE Young Innovators INTRODUCTION: Neuroinflammation and metabolic dysfunction are early alterations in Alzheimer’s disease (AD) brain that are thought to contribute to disease onset and progression. Glial activation due to protein deposition results in cytokine secretion and shifts in brain metabolism, which have been observed in AD patients. However, the mechanism by which this immunometabolic feedback loop can injure neurons and cause neurodegeneration remains unclear. METHODS: We used Luminex XMAP technology to quantify hippocampal cytokine concentrations in the 5xFAD mouse model of AD at milestone timepoints in disease development. We used partial least squares regression to build cytokine signatures predictive of disease progression, as compared to healthy aging in wild-type littermates. We applied the disease-defining cytokine signature to wild-type primary neuron cultures and measured downstream changes in gene expression using the NanoString nCounter system and mitochondrial function using the Seahorse Extracellular Flux live-cell analyzer. RESULTS: We identified a pattern of up-regulated IFNγ, IP-10/CXCL10, and IL-9 as predictive of advanced disease. When healthy neurons were exposed to these cytokines in proportions found in diseased brain, gene expression of mitochondrial electron transport chain complexes, including ATP synthase, was suppressed. In live cells, basal and maximal mitochondrial respiration were impaired following cytokine stimulation. CONCLUSIONS: We identify a pattern of cytokine secretion predictive of progressing amyloid-β pathology in the 5xFAD mouse model of AD that reduces expression of mitochondrial electron transport complexes and impairs mitochondrial respiration in healthy neurons. We establish a mechanistic link between disease-specific immune cues and impaired neuronal metabolism, potentially causing neuronal vulnerability and susceptibility to degeneration in AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12195-023-00782-y. Springer International Publishing 2023-09-11 /pmc/articles/PMC10550897/ /pubmed/37811007 http://dx.doi.org/10.1007/s12195-023-00782-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle SI: 2023 CMBE Young Innovators
Kuhn, Madison K.
Fleeman, Rebecca M.
Beidler, Lynne M.
Snyder, Amanda M.
Chan, Dennis C.
Proctor, Elizabeth A.
Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title_full Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title_fullStr Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title_full_unstemmed Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title_short Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
title_sort amyloid-β pathology-specific cytokine secretion suppresses neuronal mitochondrial metabolism
topic SI: 2023 CMBE Young Innovators
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550897/
https://www.ncbi.nlm.nih.gov/pubmed/37811007
http://dx.doi.org/10.1007/s12195-023-00782-y
work_keys_str_mv AT kuhnmadisonk amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism
AT fleemanrebeccam amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism
AT beidlerlynnem amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism
AT snyderamandam amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism
AT chandennisc amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism
AT proctorelizabetha amyloidbpathologyspecificcytokinesecretionsuppressesneuronalmitochondrialmetabolism